Among CNS tumors, PPM1D has been found to be a good prognostic marker for diffuse midline gliomas (Khadka et al., 2022), younger supratentorial diffuse astrocytic tumors, and oligodendroglial tumors (Jeong et al., 2018). The gene discussed is PPM1D; the disease is oligodendroglial tumor.